GeneDx Holdings (WGS) Other Working Capital Changes (2020 - 2026)

GeneDx Holdings (WGS) has reported Other Working Capital Changes for 7 consecutive years, with $9.1 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Other Working Capital Changes rose 1105.42% year-over-year to $9.1 million; the TTM figure through Mar 2026 stood at $11.5 million (up 262.87% YoY), while the FY2025 annual figure was $3.2 million, up 189.25% from the prior year.
• Other Working Capital Changes improved to $9.1 million in Q1 2026 per WGS's latest filing, from $781000.0 in the prior quarter.
• Across five years, Other Working Capital Changes topped out at $9.7 million in Q2 2021 and bottomed at -$9.7 million in Q3 2021.
• Historically, Other Working Capital Changes has averaged -$427200.0 across 4 years, with a median of -$951500.0 in 2020.
• On a YoY basis, Other Working Capital Changes climbed as much as 1466.79% in 2024 and fell as far as 1951.45% in 2024.
• GeneDx Holdings' Other Working Capital Changes stood at -$163000.0 in 2022, then plunged by 204.29% to -$496000.0 in 2023, then tumbled by 1146.57% to -$6.2 million in 2024, then surged by 112.63% to $781000.0 in 2025, then jumped by 1068.37% to $9.1 million in 2026.
• Business Quant data shows WGS's Other Working Capital Changes at $9.1 million in Q1 2026, $781000.0 in Q4 2025, and $995000.0 in Q3 2025.